These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

96 related articles for article (PubMed ID: 9435343)

  • 1. A new repetitive sequence uniquely present in the decay-accelerating factor genes.
    Nonaka M; Takenaka O; Okada N; Okada H
    Immunogenetics; 1998; 47(3):246-55. PubMed ID: 9435343
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Alternative exon usage in the 3' region of a single gene generates glycosylphosphatidylinositol-anchored and transmembrane forms of rat decay-accelerating factor.
    Miwa T; Okada N; Okada H
    Immunogenetics; 2000 Feb; 51(2):129-37. PubMed ID: 10663575
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Multiple isoforms of guinea pig decay-accelerating factor (DAF) generated by alternative splicing.
    Nonaka M; Miwa T; Okada N; Nonaka M; Okada H
    J Immunol; 1995 Sep; 155(6):3037-48. PubMed ID: 7545710
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Conservation in decay accelerating factor (DAF) structure among primates.
    Kuttner-Kondo L; Subramanian VB; Atkinson JP; Yu J; Medof ME
    Dev Comp Immunol; 2000 Dec; 24(8):815-27. PubMed ID: 10906393
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pigs express multiple forms of decay-accelerating factor (CD55), all of which contain only three short consensus repeats.
    Pérez de la Lastra JM; Harris CL; Hinchliffe SJ; Holt DS; Rushmere NK; Morgan BP
    J Immunol; 2000 Sep; 165(5):2563-73. PubMed ID: 10946283
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Molecular cloning of murine decay accelerating factor by immunoscreening.
    Fukuoka Y; Yasui A; Okada N; Okada H
    Int Immunol; 1996 Mar; 8(3):379-85. PubMed ID: 8671624
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Structure of the gene for human complement protein decay accelerating factor.
    Post TW; Arce MA; Liszewski MK; Thompson ES; Atkinson JP; Lublin DM
    J Immunol; 1990 Jan; 144(2):740-4. PubMed ID: 1688584
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cloning and characterization of cDNAs encoding the complete sequence of decay-accelerating factor of human complement.
    Medof ME; Lublin DM; Holers VM; Ayers DJ; Getty RR; Leykam JF; Atkinson JP; Tykocinski ML
    Proc Natl Acad Sci U S A; 1987 Apr; 84(7):2007-11. PubMed ID: 2436222
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tau gene (MAPT) sequence variation among primates.
    Holzer M; Craxton M; Jakes R; Arendt T; Goedert M
    Gene; 2004 Oct; 341():313-22. PubMed ID: 15474313
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evolution of pro-protamine P2 genes in primates.
    Retief JD; Dixon GH
    Eur J Biochem; 1993 Jun; 214(2):609-15. PubMed ID: 8513810
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mouse complement regulatory protein Crry/p65 uses the specific mechanisms of both human decay-accelerating factor and membrane cofactor protein.
    Kim YU; Kinoshita T; Molina H; Hourcade D; Seya T; Wagner LM; Holers VM
    J Exp Med; 1995 Jan; 181(1):151-9. PubMed ID: 7528766
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Molecular cloning and chromosomal localization of the mouse decay-accelerating factor genes. Duplicated genes encode glycosylphosphatidylinositol-anchored and transmembrane forms.
    Spicer AP; Seldin MF; Gendler SJ
    J Immunol; 1995 Sep; 155(6):3079-91. PubMed ID: 7545711
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cloning of decay-accelerating factor suggests novel use of splicing to generate two proteins.
    Caras IW; Davitz MA; Rhee L; Weddell G; Martin DW; Nussenzweig V
    Nature; 1987 Feb 5-11; 325(6104):545-9. PubMed ID: 2433596
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The human Nramp2 gene: characterization of the gene structure, alternative splicing, promoter region and polymorphisms.
    Lee PL; Gelbart T; West C; Halloran C; Beutler E
    Blood Cells Mol Dis; 1998 Jun; 24(2):199-215. PubMed ID: 9642100
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Nucleotide sequence of the gene for the b subunit of human factor XIII.
    Bottenus RE; Ichinose A; Davie EW
    Biochemistry; 1990 Dec; 29(51):11195-209. PubMed ID: 2271707
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mechanisms by which the surface expression of the glycosyl-phosphatidylinositol-anchored complement regulatory proteins decay-accelerating factor (CD55) and CD59 is lost in human leukaemia cell lines.
    Hatanaka M; Seya T; Matsumoto M; Hara T; Nonaka M; Inoue N; Takeda J; Shimizu A
    Biochem J; 1996 Mar; 314 ( Pt 3)(Pt 3):969-76. PubMed ID: 8615796
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Structural characterization of mouse CD97 and study of its specific interaction with the murine decay-accelerating factor (DAF, CD55).
    Qian YM; Haino M; Kelly K; Song WC
    Immunology; 1999 Oct; 98(2):303-11. PubMed ID: 10540231
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Molecular and functional analysis of mouse decay accelerating factor (CD55).
    Harris CL; Rushmere NK; Morgan BP
    Biochem J; 1999 Aug; 341 ( Pt 3)(Pt 3):821-9. PubMed ID: 10417349
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Structural and functional differences in the dio1 gene in mice with inherited type 1 deiodinase deficiency.
    Maia AL; Berry MJ; Sabbag R; Harney JW; Larsen PR
    Mol Endocrinol; 1995 Aug; 9(8):969-80. PubMed ID: 7476994
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Characterization of DAF-2, a high molecular weight form of decay-accelerating factor (DAF; CD55), as a covalently cross-linked dimer of DAF-1.
    Nickells MW; Alvarez JI; Lublin DM; Atkinson JP
    J Immunol; 1994 Jan; 152(2):676-85. PubMed ID: 7506731
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.